The Recall Desk
HighFDA (Devices)·Z-0198-2024·Announced 2023-11-08

RX Daytona Plus clinical chemistry analyzer may report incorrect test results

The RX Daytona Plus clinical chemistry analyzer may report incorrect results when samples fall outside normal range and the automatic rerun feature malfunctions. Randox Laboratories is recalling 5 units distributed nationwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is a FDA Class II medical device recall involving potential for incorrect test result reporting when samples are outside normal range. This represents a risk-of-harm product where injury has not yet been reported, meeting the rubric criterion for High severity.

Plain-English summary

The RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser, Catalog Number RX4040, is being recalled due to defects in its automatic rerun feature. This laboratory instrument is used to analyze clinical chemistry samples.

The device's rerun settings for sample volume levels and automatic dilutions do not properly handle samples that fall above or below the expected assay range. When the device attempts to automatically rerun such samples, it may not meet the correct rerun conditions, potentially resulting in incorrect test result reporting.

The recall affects 5 units with nationwide distribution, including Puerto Rico. The affected lot numbers are 7241-0551, 7241-0545, 7241-0531, 7241-0317, and 7241-0219.

Users of affected devices should contact Randox Laboratories Ltd. to report any suspected issues and determine appropriate steps for device servicing or replacement.

The recalled product

Product
RX Daytona Plus (with ISE)-IVD Clinical Chemistry Analyser Catalog Number: RX4040
Manufacturer
Randox Laboratories Ltd.
Hazard
  • incorrect-test-results
  • sample-rerun-malfunction

Distribution

Distributed nationwide across the United States.